382 related articles for article (PubMed ID: 16311407)
21. Newer Concepts in the Classification of Pituitary Adenomas.
Sathyakumar R; Chacko G
Neurol India; 2020; 68(Supplement):S7-S12. PubMed ID: 32611886
[TBL] [Abstract][Full Text] [Related]
22. Pathology of pituitary tumors.
Sanno N; Teramoto A; Osamura RY; Horvath E; Kovacs K; Lloyd RV; Scheithauer BW
Neurosurg Clin N Am; 2003 Jan; 14(1):25-39, vi. PubMed ID: 12690977
[TBL] [Abstract][Full Text] [Related]
23. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
24. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification.
Ho DM; Hsu CY; Ting LT; Chiang H
Histopathology; 2001 Sep; 39(3):310-9. PubMed ID: 11532042
[TBL] [Abstract][Full Text] [Related]
25. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
[TBL] [Abstract][Full Text] [Related]
26. Clinical and cytofunctional classification of pituitary adenomas: proposal of a new classification.
Sanno N; Teramoto A; Osamura RY
Acta Neurochir (Wien); 1996; 138(10):1186-92. PubMed ID: 8955438
[TBL] [Abstract][Full Text] [Related]
27. The pathology of pituitary tumors.
Asa SL
Endocrinol Metab Clin North Am; 1999 Mar; 28(1):13-43, v-vi. PubMed ID: 10207684
[TBL] [Abstract][Full Text] [Related]
28. Invasive, atypical and aggressive pituitary adenomas and carcinomas.
Sav A; Rotondo F; Syro LV; Di Ieva A; Cusimano MD; Kovacs K
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):99-104. PubMed ID: 25732646
[TBL] [Abstract][Full Text] [Related]
29. Conventional examination versus immunohistochemistry in the prediction of hormone profile of pituitary adenomas. An analysis on 142 cases.
Bălinişteanu B; Ceauşu RA; Cîmpean AM; Baciu I; Băculescu N; Coculescu M; Raica M
Rom J Morphol Embryol; 2011; 52(3 Suppl):1041-5. PubMed ID: 22119822
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic correlates of giant pituitary adenomas.
Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
[TBL] [Abstract][Full Text] [Related]
31. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.
Saeger W; Lüdecke DK; Buchfelder M; Fahlbusch R; Quabbe HJ; Petersenn S
Eur J Endocrinol; 2007 Feb; 156(2):203-16. PubMed ID: 17287410
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
[TBL] [Abstract][Full Text] [Related]
33. Pituitary gland.
Horvath E; Kovacs K
Pathol Res Pract; 1988 Apr; 183(2):129-42. PubMed ID: 3290865
[TBL] [Abstract][Full Text] [Related]
34. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
[TBL] [Abstract][Full Text] [Related]
35. Expression of leukemia inhibitory factor in human pituitary adenomas: a morphologic and immunocytochemical study.
Kontogeorgos G; Patralexis H; Tran A; Kovacs K; Melmed S
Pituitary; 2000 May; 2(4):245-51. PubMed ID: 11081145
[TBL] [Abstract][Full Text] [Related]
36. Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.
Gomez-Hernandez K; Ezzat S; Asa SL; Mete Ö
Turk Patoloji Derg; 2015; 31 Suppl 1():4-17. PubMed ID: 26177314
[TBL] [Abstract][Full Text] [Related]
37. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.
Asa SL; Casar-Borota O; Chanson P; Delgrange E; Earls P; Ezzat S; Grossman A; Ikeda H; Inoshita N; Karavitaki N; Korbonits M; Laws ER; Lopes MB; Maartens N; McCutcheon IE; Mete O; Nishioka H; Raverot G; Roncaroli F; Saeger W; Syro LV; Vasiljevic A; Villa C; Wierinckx A; Trouillas J;
Endocr Relat Cancer; 2017 Apr; 24(4):C5-C8. PubMed ID: 28264912
[TBL] [Abstract][Full Text] [Related]
38. The differential diagnosis of lesions involving the sella turcica.
Kovacs K; Horvath E
Endocr Pathol; 2001; 12(4):389-95. PubMed ID: 11914472
[TBL] [Abstract][Full Text] [Related]
39. Hormone markers in pituitary adenomas: changes within last decade resulting from improved method.
Saeger W; Wilczak W; Lüdecke DK; Buchfelder M; Fahlbusch R
Endocr Pathol; 2003; 14(1):49-54. PubMed ID: 12746562
[TBL] [Abstract][Full Text] [Related]
40. Use of immunohistochemical and morphologic methods for the identification of human growth hormone-producing pituitary adenomas.
Nieuwenhuyzen Kruseman AC; Bots GT; Lindeman J; Schaberg A
Cancer; 1976 Sep; 38(3):1163-70. PubMed ID: 782686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
